Carlina oxide-based biopesticide for brown planthopper control
Carlina oxide is a promising natural biopesticide derived from Carlina L. genus plants, effective against brown planthoppers in rice cultivation. It offers an eco-friendly alternative to commercial insecticides with limited non-target toxicity. Ongoing research aims to optimize its formulation and application.
Overview
Carlina oxide, a polyacetylene compound derived from the Carlina L. genus, is being developed as a natural biopesticide to control brown planthoppers in rice cultivation. This compound has shown significant effectiveness in controlling various agricultural pests, offering a safer alternative to traditional chemical insecticides. Its potential aligns with European "Farm to Fork" and "Biodiversity" strategies, focusing on sustainable agricultural practices.
Technical specifications
The biopesticide formulation leverages carlina oxide's natural pesticidal properties, which have been proven effective in both laboratory and field conditions. Key features include:
- High efficacy: Demonstrates greater effectiveness than some commercial insecticides.
- Eco-friendly: Shows acceptable biocompatibility with limited toxicity on non-target organisms.
- Synthetic adaptability: The compound can be synthesized and encapsulated in formulations for improved delivery and efficacy.
- Targeted application: Research is focused on optimizing formulations to enhance selectivity and minimize dosage requirements.
Technology readiness level
The development of carlina oxide-based biopesticide is at Technology Readiness Level 5, indicating that it has been validated in relevant environments. Current research focuses on further testing in laboratory and open field conditions, as well as formulation optimization to enhance effectiveness and reduce environmental impact.
About University of Camerino
The University of Camerino is a public, multi‑campus research university in central Italy, combining a close‑knit scale with global engagement. Industry collaboration is coordinated by a technology‑transfer and project‑management office that maps expertise, supports proposals and IP, and accelerates spin‑offs. Co‑located assets include a university veterinary teaching hospital in Matelica and earthquake‑resilient research spaces for clinical services, prototyping and testing. Research draws on competitive European and Italian funding, with staff monitoring calls and managing projects; commercialization covers IP, licensing and startups, supported by an annual business‑plan competition.
delivered to your inbox.